FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)

View source ↗

Summary

FDA approved a supplemental application for DELFLEX, a dialysate solution, submitted by Fresenius Medical Care North America.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• DELFLEX (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE)

Snippet

SUPPL AP for DELFLEX (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE)